Journal for ImmunoTherapy of Cancer (Nov 2023)
1449 NCG-M is a triple immunodeficient mouse with increased reconstitution of human myeloid cell populations for use in immunotherapy preclinical research
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)